|
|
|
|
| LEADER |
00000cam a2200000Mi 4500 |
| 001 |
on1058439747 |
| 003 |
OCoLC |
| 005 |
20240504213016.0 |
| 006 |
m o d |
| 007 |
cr |n|---||||| |
| 008 |
151110t20162016ne a ob 001 0 eng d |
| 040 |
|
|
|a AU@
|b eng
|e rda
|e pn
|c AU@
|d NLE
|d EBLCP
|d MERUC
|d OCLCO
|d OCLCQ
|d OCLCF
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|d SFB
|
| 019 |
|
|
|a 927490067
|a 932056280
|
| 020 |
|
|
|a 0128023716
|
| 020 |
|
|
|a 9780128023716
|
| 020 |
|
|
|a 0128021896
|
| 020 |
|
|
|a 9780128021897
|
| 035 |
|
|
|a (OCoLC)1058439747
|z (OCoLC)927490067
|z (OCoLC)932056280
|
| 037 |
|
|
|a 9780128023716
|b Ingram Content Group
|
| 050 |
|
4 |
|a RM666.P835
|b .P763 2016
|
| 049 |
|
|
|a HCDD
|
| 100 |
1 |
|
|a Watson, Ronald R.
|q (Ronald Ross)
|1 https://id.oclc.org/worldcat/entity/E39PCjGgxC47cmCfdqyH6Y7xH3
|
| 245 |
1 |
0 |
|a Probiotics, prebiotics, and synbiotics :
|b bioactive foods in health promotion /
|c edited by Ronald Ross Watson, Victor R. Preedy.
|
| 250 |
|
|
|a 2nd ed.
|
| 264 |
|
1 |
|a Amsterdam, Netherlands :
|b Academic Press,
|c 2016.
|
| 264 |
|
4 |
|c ©2016
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 504 |
|
|
|a Includes bibliographical references at the end of each chapters and index.
|
| 546 |
|
|
|a English.
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (ebrary, viewed November 10, 2015).
|
| 505 |
0 |
|
|a Front Cover -- Probiotics, Prebiotics, and Synbiotics: Bioactive Foods in Health Promotion -- Copyright -- Contents -- Contributors -- Preface -- Prebiotics in Health Promotion -- Probiotics in Foods -- Synbiotics: Production, Application, and Health Promotion -- Probiotics in Health -- Probiotics and Chronic Diseases -- Acknowledgments -- Biographies -- Part I: Prebiotics in Health Promotion -- Chapter 1: Prebiotics and Probiotics: An Assessment of Their Safety and Health Benefits -- 1 Introduction -- 2 Prebiotic Concept -- 3 Use of Prebiotics -- 3.1 Use of Prebiotic as Medical Purposes -- 3.2 Prebiotic Sources -- 3.2.1 Fructans -- 3.2.2 Resistant Starch -- 3.3 Prebiotics and Resistance to Gastrointestinal Infections -- 4 Evaluation of Prebiotic -- 4.1 AFCSF Product Specification/Characteristics of the Prebiotic -- 4.2 Functionality -- 4.3 Qualifications -- 4.4 Safety -- 5 Probiotics Used in Food -- 6 Synbiotic -- 7 Safety Aspect of Probiotics -- 7.1 In Vitro Studies -- 7.2 Animal Studies -- 7.3 Noninvasive Tests in Animal Models and Humans -- 7.4 Studies in Humans -- 7.5 Epidemiological and Postmarketing Surveillance -- 7.5.1 Genotoxicity Studies Including Mutagenicity -- 7.5.2 Toxin Production and Virulence Factors -- 7.5.3 Antibiotic Resistance Profile and Transferability of Resistances -- 8 Prebiotic and Probiotic Efficacy Evidence -- 8.1 In Vitro Evidence -- 8.2 Animal Models -- 8.3 Human Cases Studies -- 8.4 Human Trials -- 9 Prebiotic and Probiotic Claims -- 9.1 European Union -- 9.1.1 Organization and Content of the Application -- 9.2 The United States -- 10 Qualified Presumption of Safety ( QPS) Concept of MicroOrganisms Used in Food -- 10.1 Taxonomic Status of Candidate Organisms for QPS Assessment -- 10.2 Purpose and Advantages of QPS -- 10.3 Requirements of QPS -- 11 Conclusion -- Acknowledgments -- References.
|
| 505 |
8 |
|
|a Chapter 2: Pre- and Probiotic Supplementation in Ruminant Livestock Production -- 1 Introduction -- 2 The Ruminant -- 2.1 Anatomy and Physiology of the Ruminant Gastrointestinal Tract -- 2.2 The Ruminant Gut Microbiota -- 2.3 Microbial Stimulation of Regulatory Immune Mechanisms -- 2.4 Microbial Contributions to Ruminant Nutrition and Metabolism -- 3 Prebiotics -- 3.1 Prebiotic Substances -- 3.2 Prebiotics and Their Effect on Probiotic Supplementation and the Gut Microbiota -- 4 Probiotics -- 4.1 Probiotic Species and Blends -- 4.2 Probiotics: Ruminant Performance -- 4.2.1 Probiotics in Ruminant Maturation and Development -- 4.2.2 Probiotic Effects on Growth and Performance -- 4.2.3 Probiotics and Dairy Cows -- 4.2.4 Probiotics: Ruminant Disease Management and Health Promotion -- 4.2.5 Probiotics and Gastrointestinal Diseases -- 4.2.6 Probiotics and Ruminal Acidosis -- 4.2.7 Probiotics and Environmentally Induced Stress -- 4.3 Probiotics, Methanogens, and the Environment -- 5 Discussion and Conclusions -- References -- Chapter 3: Prebiotic Addition in Dairy Products: Processing and Health Benefits -- 1 Functional Foods -- 2 Prebiotic Ingredients -- 3 ß -Glucan -- 4 Resistant Starch -- 5 Inulin-Type Fructans -- 6 The Role of Fructans in Plants -- 7 Chemical Structure of Fructans -- 8 Physicochemical Properties of Inulin -- 9 Structural and Rheological Aspects -- 10 Inulin as a Fat Replacer -- 11 Effects of Process and Process Conditions -- 12 Oligofructose -- 13 Functional Effects of Prebiotics on the Health -- 14 Sensory Aspects -- 15 Prebiotics in Dairy Products -- 16 Perspectives -- References -- Chapter 4: Low-Lactose, Prebiotic-Enriched Milk -- 1 Human Milk Oligosaccharides -- 2 Galacto-Oligosaccharides (GOS) and Fructo-Oligosaccharides (FOS) in Dairy Products -- 3 Enzymatic Synthesis of GOS -- 4 In Situ Formation of GOS in Milk.
|
| 505 |
8 |
|
|a 5 GOS Formation in Milk with ß -Galactosidase from B. circulans -- 6 GOS Formation in Milk with ß -Galactosidase from K. lactis -- 7 Effect of Temperature on GOS Formation in Milk -- 8 Proposed Method to Obtain Low-Lactose, Milk-Enriched in GOS -- References -- Chapter 5: Intestinal Microbiota in Breast-Fed Infants: Insights into Infant-Associated Bifidobacteria and Human Milk Glycans -- 1 Introduction -- 2 Intestinal Microbiota in Breast-Fed Infants -- 3 Human Milk Composition and Complexity -- 4 Antimicrobial Activities in Human Milk -- 5 Human Milk Glycans -- 6 HMO Structures and Properties -- 7 Structure-Function Relationships of HMOs -- 8 Bifidobacterial Strategies of HMO Consumption -- 9 Human Milk Glycoproteins and Glycolipids -- 10 Consumption of Human Milk Glycoconjugates by Bifidobacteria -- 11 Bifidobacteria and Health Benefits to the Infant -- 12 Infant Formula -- 13 Conclusions -- Acknowledgments -- References -- Chapter 6: Probiotics and Prebiotics for Promoting Health: Through Gut Microbiota -- 1 Introduction -- 2 Human Gut Microbiota: Complexities, Diversities, Functionalities -- 3 Gut Microbiota Balance in the Triangle of Nutrition, Health, and Disease -- 4 Factors Influencing the Gut Microbiota -- 5 Modulation of Gut Microbiota Composition -- 6 Probiotics: Foundation and Definition -- 7 Health Benefits of Probiotics -- 8 Probiotics' Effects on Intestinal Microbiota and Environment -- 9 Prebiotics -- 10 Future Prospects and Expectations -- References -- Chapter 7: Prebiotics in Human Milk and in Infant Formulas -- 1 Introduction -- 2 Development of the Immune System in Infants -- 3 Breast Milk and Defense Against Infections and Allergic Manifestations -- 4 What Are Prebiotics? -- 5 Human Milk Oligosaccharides -- 6 Prebiotics in Infant Formulas -- 7 Side Effects -- 8 Regulation of the Addition of Prebiotics to Infant Formulas.
|
| 505 |
8 |
|
|a 9 Conclusions -- References -- Chapter 8: Prebiotics and Probiotics in Infant Nutrition -- 1 Introduction -- 2 Development and Physiology of the Gastrointestinal Ecosystem -- 3 Prebiotics -- 3.1 Definition -- 3.2 Characteristics -- 4 Human Milk Oligosaccharides -- 5 Nonhuman Milk Oligosaccharides -- 5.1 Oligosaccharides from Animal Milks -- 5.2 Nonmilk Oligosaccharides -- 5.3 Mechanisms of Action -- 5.4 Side Effects -- 6 Probiotics -- 6.1 Definition -- 6.2 Characteristics -- 6.3 Mechanisms of Action -- 6.4 Side Effects -- 7 Symbiotics -- 8 Use of Prebiotics in Pediatrics -- 8.1 Nonmilk Oligosaccharides and Prebiotic Effects of Breast Milk -- 8.2 Nonmilk Oligosaccharides and the Prevention of Infections and Allergies -- 8.3 Nonmilk Oligosaccharides and Other Effects -- 9 Use of Probiotics in Pediatrics -- 10 Acute Diarrhea -- 10.1 Antibiotic-Associated Diarrhea -- 10.2 Necrotizing Enterocolitis -- 10.3 Allergy -- 11 Other Pediatric Uses -- 11.1 Constipation -- 11.2 Inflammatory Bowel Disease -- 11.3 Irritable Bowel Syndrome -- 11.4 Helicobacter pylori Infection -- 11.5 Lactose Intolerance -- 11.6 Respiratory Tract Infections -- 11.7 Urinary Tract Infections -- 11.8 Obesity and Diabetes -- 11.9 Prebiotics and Probiotics in Infant Formulas -- 12 Conclusion -- References -- Chapter 9: Synthesis of Prebiotic Galacto-Oligosaccharides: Science and Technology -- 1 Introduction -- 2 Galacto-Oligosaccharides ( GOS): Chemical Synthesis vs. Biocatalysis -- 3 Synthesis of GOS Using Galactosyltransferases -- 4 Synthesis of GOS Using ß -Galactosidases -- 4.1 Mechanism of Catalysis by ß -Galactosidases -- 4.2 Hydrolysis vs. Transgalactosylation During Lactose Hydrolysis by ß -Galactosidases -- 4.3 Factors Affecting GOS Synthesis Using ß -Galactosidases -- 4.3.1 Initial Lactose Concentration -- 4.3.2 Temperature -- 4.3.3 Enzyme Source -- 4.3.4 GOS Synthesis Time.
|
| 505 |
8 |
|
|a 4.3.5 Other Factors ( pH and Inhibitors) -- 4.4 Degree of Polymerization and Glycosidic Linkages in GOS Mixtures -- 5 Types of Biocatalysts Used in GOS Synthesis -- 5.1 Whole Cell Biocatalysts -- 5.2 Free ß -Galactosidases -- 5.3 Recombinant ß -Galactosidases -- 6 Improving the GOS Synthesis Process -- 6.1 Immobilization of ß -Galactosidases -- 6.1.1 Methods of ß -Galactosidase Immobilization -- 6.1.1.1 Cross-linking -- 6.1.1.2 Carrier Binding -- 6.1.1.2.1 Covalent Binding -- 6.1.1.2.2 Noncovalent Binding -- 6.1.1.3 Inclusion -- 6.2 Protein Engineering -- 6.3 Reaction Medium Engineering -- 7 Future Developments -- References -- Chapter 10: Prebiotics as Protectants of Lactic Acid Bacteria -- 1 Introduction -- 2 Physical Chemistry of the Preservation of Lactic Acid Bacteria and Probiotics -- 3 Use of Prebiotics as Protectants of Starters -- 4 Prebiotics as Probiotic Protectants in Food Matrices -- 5 Prebiotics as Probiotic Protectants in the Gastrointestinal Tract -- 6 Conclusions -- References -- Chapter 11: Prebiotic Agave Fructans and Immune Aspects -- 1 Chapter Points -- 2 Introduction -- 3 Agave Plant: Origin and the Role of Fructans -- 4 Chemical Structures of Agave Fructans -- 5 Overview of the Immune System -- 5.1 Innate Immunity -- 5.2 Acquired Immunity -- 5.3 Gut-Associated Lymphoid Tissue -- 6 Mechanism of Prebiotics -- 7 Health Implication of Agave Fructans: In Vivo and In Vitro Studies -- 7.1 Prebiotic Effect -- 7.2 Obesity, Blood Lipids, and Cholesterol -- 7.3 Toxicological Studies -- 7.4 Immunological Studies -- 7.5 Cancer -- 8 Discussion of Immune Aspects of Agave Fructans -- 9 Conclusions -- Acknowledgments -- References -- Chapter 12: Prebiotics Use in Children -- 1 Introduction -- 2 Prebiotics and Short-Chain Fatty Acids -- 3 Clinical Effects in Children -- 3.1 Gastrointestinal Transit and Resorption of Nutrients.
|
| 650 |
|
0 |
|a Probiotics.
|
| 650 |
|
0 |
|a Functional foods.
|
| 650 |
|
7 |
|a Functional foods
|2 fast
|
| 650 |
|
7 |
|a Probiotics
|2 fast
|
| 700 |
1 |
|
|a Watson, Ronald R.
|q (Ronald Ross),
|e editor.
|1 https://id.oclc.org/worldcat/entity/E39PCjGgxC47cmCfdqyH6Y7xH3
|
| 700 |
1 |
|
|a Preedy, Victor R.,
|e editor.
|
| 758 |
|
|
|i has work:
|a Probiotics, prebiotics, and synbiotics (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCH7RWwXcjCdfkxpJBhcHG3
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version
|z 9780128021897
|
| 856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=4003870
|y Click for online access
|
| 903 |
|
|
|a EBC-AC
|
| 994 |
|
|
|a 92
|b HCD
|